Results 51 to 60 of about 4,356 (97)
Ocular Pharmacokinetic/Pharmacodynamic Modeling for Timolol in Rabbits Using a Telemetry System
, 2008 Koji Sakanaka +8 more
openalex +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Journal of Australia, 1979
A randomized, double-masked trial of various concentrations of timolol maleate ophthalmic solution (0.1%, 0.25%, 0.5%, and 1.0%) vs placebo demonstrated that all concentrations of timolol effectively lowered intraocular pressure (IOP). A 0.5% solution of timolol was as effective in reducing IOP as the 1.0% concentration.
Michael E. Yablonski +3 more
openaire +5 more sources
A randomized, double-masked trial of various concentrations of timolol maleate ophthalmic solution (0.1%, 0.25%, 0.5%, and 1.0%) vs placebo demonstrated that all concentrations of timolol effectively lowered intraocular pressure (IOP). A 0.5% solution of timolol was as effective in reducing IOP as the 1.0% concentration.
Michael E. Yablonski +3 more
openaire +5 more sources
Archives of Ophthalmology, 1981
To the Editor. —There is increasing evidence of systemic side effects secondary to topical ocular administration of timolol maleate for the treatment of glaucoma. 1,2 These systemic side effects are essentially the same as those seen from systemically administered β-blockers.
E. Michael Van Buskirk +1 more
openaire +3 more sources
To the Editor. —There is increasing evidence of systemic side effects secondary to topical ocular administration of timolol maleate for the treatment of glaucoma. 1,2 These systemic side effects are essentially the same as those seen from systemically administered β-blockers.
E. Michael Van Buskirk +1 more
openaire +3 more sources
Vestnik oftal'mologii, 2019
In recent years, β-adrenergic blockers have become the first choice drugs for glaucoma treatment. Timolol holds the main position among them, being a part of most combined antiglaucoma preparations. The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems.
K. I. Turkina +3 more
openaire +2 more sources
In recent years, β-adrenergic blockers have become the first choice drugs for glaucoma treatment. Timolol holds the main position among them, being a part of most combined antiglaucoma preparations. The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems.
K. I. Turkina +3 more
openaire +2 more sources
Drugs & Aging, 2006
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Susan J Keam +2 more
openaire +3 more sources
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Susan J Keam +2 more
openaire +3 more sources